- Chunmei Li, Hui Li, Ming Gong, Jia Wei. Osteopenia in a young man associated with the use of tenofovir disoproxil fumarate. Clinical Case Reports 2022;10

- Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis. Hepatobiliary & Pancreatic Diseases International 2020;19:507

- Ayşin Kılınç Toker, Azade Kanat, Ayşe Turunç Özdemır, Esma Eryılmaz Eren, Duygu Çerçioğlu, Deniz Kamalak Güzel, Tuğba Tok, Zehra Beştepe Dursun, Musa Göksu, İlhami Çelik. Evaluation of clinical characteristics and treatment patterns of patients infected with hepatitis B. J Med Palliat Care / JOMPAC / Jompac 2024;5:42

- Tingyan Wang, David A. Smith, Cori Campbell, Jolynne Mokaya, Oliver Freeman, Hizni Salih, Anna L. McNaughton, Sarah Cripps, Kinga A. Várnai, Theresa Noble, Kerrie Woods, Jane Collier, Katie Jeffery, Jim Davies, Eleanor Barnes, Philippa C. Matthews. Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study. BMC Infect Dis 2021;21

- Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, Khin Maung Win, Khin Pyone Kyi, Kyaw Soe Tun, Mohd. Salih, Mukul Rastogi, Neeraj Saraf, Pham Thi Thu Thuy, Pham Tran Dieu Hien, Rino Alvani Gani, Rosmawati Mohamed, Tawesak Tanwandee, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Win Naing, Zahid Yasin Hashmi. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol 2020;55:811

- . Tenofovir-disoproxil-fumarate. Reactions Weekly 2019;1740:314

- Shuhei Hige, Kouji Aoki, Daisuke Nakamoto, John F. Flaherty, Irina Botros, Hajime Mizutani, Akinobu Ishizaki, Hiroki Konishi, Jason Yuan, Masahisa Jinushi, Leslie J. Ng. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B. Journal of Viral Hepatitis 2024;31:165

- Shuqin Zheng, Longgen Liu, Jianchun Lu, Xiujun Zhang, Hongyu Shen, Hongyu Zhang, Yuan Xue, Lin Lin. Efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B virus infection. 2019;98:e17590

- Young‐Suk Lim, Wai‐Kay Seto, Masayuki Kurosaki, Scott Fung, Jia‐Horng Kao, Jinlin Hou, Stuart C. Gordon, John F. Flaherty, Leland J. Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico. Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data. Aliment Pharmacol Ther 2022;55:921

- David E. Bernstein, Huy N. Trinh, Eugene R. Schiff, Coleman I. Smith, Andrea R. Mospan, Richard C. Zink, Michael W. Fried, Anna S. Lok. Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV. Dig Dis Sci 2022;67:2637

- Pietro Lampertico, Thomas Berg, Maria Buti, Anita Pathil, Joerg Petersen, Stephen D. Ryder, Fabien Zoulim, Irina Botros, John F. Flaherty, Belinda Jump, Marjoleine L. Op den Brouw, Anna van Troostenburg, Heribert Ramroth. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study. Aliment Pharmacol Ther 2020;52:500

- Jolynne Mokaya, Tongai G Maponga, Anna L McNaughton, Marije Van Schalkwyk, Susan Hugo, Joshua B Singer, Vattipally B Sreenu, David Bonsall, Mariateresa de Cesare, Monique Andersson, Shiraaz Gabriel, Jantje Taljaard, Eleanor Barnes, Wolfgang Preiser, Christo Van Rensburg, Philippa C Matthews. Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults. Journal of Clinical Virology 2020;129:104548

- En-Ling Wu, Beatrice Christian, Adovich S Rivera, Emanuel Fabian, Irene Macha, Eric Aris, Shida Mpangala, Nzovu Ulenga, Ferdinand Mugusi, Robert L Murphy, Claudia A Hawkins. Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. 2024;79:36

- Luisa Roade, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti. Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B. Therapeutic Advances in Infection 2021;8
